Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2732 of 5804
-
New drug combo targets Hard-to-Treat skin cancer
Disease control TerminatedThis is an open label, single center, non-randomized dose de-escalation phase I study of combination of BV and Mogamulizumab. The primary objective of the study is to assess the safety and tolerability of the combination. The primary objective is also to explore safe dose of com…
Phase: PHASE1 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New sperm device aims to improve embryo development in IVF
Disease control CompletedProspective, multi-centric, split-sample, sibling oocyte study evaluating the safety and efficacy of a new method to prepare sperm samples for IVF (in vitro fertilization) / ICSI (intracytoplasmic sperm injection) compared to standard procedures.
Phase: NA • Sponsor: Fecundis S.A. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New online tool aims to ease Cancer's hidden toll on patients and families
Symptom relief Recruiting nowThis clinical trial studies how well a web-based dyadic intervention works to manage psychoneurological symptoms for patients with colorectal cancer and their caregivers. Patients with colorectal cancer receiving chemotherapy experience severe and distressing psychoneurological s…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Large study aims to uncover best treatments for lymphoma patients with dangerous immune reaction
Knowledge-focused Recruiting nowThe purpose of the study is to describe Hemophagocytic lymphohistiocytosis (HLH) in patients with lymphoma to identify possible therapeutic strategies to improve overall survival of the patients with lymphoma associated hemophagocytic lymphohistiocytosis.
Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Lung cancer biopsy study: fewer needle passes may be enough for genetic tests
Knowledge-focused OngoingIn this monocentric randomized controlled trial, 120 potential non small cell lung cancer (NSCLC) patients for which tissue diagnosis and material for next generation sequencing (NGS) is required for clinical management will be approached the day of their endobronchial ultrasound…
Phase: NA • Sponsor: Institut universitaire de cardiologie et de pneumologie de Québec, University Laval • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC
-
Virtual reality may ease chemo brain in cancer survivors
Symptom relief Recruiting nowOncoBRAIN aims to assess the effect of an innovative immersive virtual reality-based (IVR) intervention that includes cognitive, physical activity and mindfulness exercises in people diagnosed with cancer and Chemotherapy-Related Cognitive Deficits (CRCD). The main objective of O…
Phase: NA • Sponsor: Consorci Sanitari de Terrassa • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
New program aims to keep young diabetics on track with glucose monitoring
Disease control OngoingThe goal of this clinical trial is to evaluate the efficacy of an adapted FAMS (Family/friend Activation to Motivate Self-care) intervention on CGM use among study participants who are CGM users. We will leverage the infrastructure of an NIDDK-funded RCT evaluating FAMS-T1D among…
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Can Phone-Based care ease anxiety in epilepsy patients?
Symptom relief Recruiting nowThe purpose of this research is to evaluate a 6 month change in quality of life in subjects who receive collaborative care calls compared to those subjects who receive usual neurology care. This is a 2-site trial comparing a 24 week neurology-based collaborative care program to u…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
New powder dressing could cut bedsore dressing changes
Disease control Recruiting nowPressure injuries, commonly known as pressure ulcers, affect over 2.5 million people in the United States. Pressure injuries are classified into four escalating stages, from intact skin to full thickness wounds with deep tissue loss and exposed bone. This study will compare curre…
Phase: NA • Sponsor: ULURU Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Brotherly advice: sibling talks may boost HIV prevention
Prevention CompletedThis is a randomized controlled trial with an attention placebo control group. The goal of this study is to decrease HIV incidence in Latino men who have sex with men by engaging their siblings in PrEP-use promotion. In the intervention arm, siblings will be trained to engage the…
Phase: NA • Sponsor: Charles Drew University of Medicine and Science • Aim: Prevention
Last updated Jun 27, 2026 12:04 UTC
-
Rwanda family program aims to heal trauma and build resilience
Knowledge-focused CompletedThis cluster-randomized waitlist-control trial evaluated Multifamily Healing Spaces (MFHS), a culturally adapted behavioral family intervention for genocide-affected communities in Rwanda. Community members across five districts were screened through a staged triage process. Indi…
Phase: NA • Sponsor: Alexandros Lordos, PhD • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Empathy training for cancer doctors aims to erase lung cancer stigma
Knowledge-focused Recruiting nowResearch indicates that perceived stigma within medical encounters is prevalent and problematic for lung cancer patients' well-being and quality of cancer care. Promoting empathic communication appears to be a potentially effective intervention target to help reduce patients' per…
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
New drug combo takes on advanced cancers in early human test
Disease control Recruiting nowThis study will assess the safety and tolerability of EBC-129 as a single agent and in combination with pembrolizumab in patients with advanced solid tumours
Phase: PHASE1 • Sponsor: EDDC (Experimental Drug Development Centre), A*STAR Research Entities • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New drug shows promise for Long-Term ulcerative colitis control
Disease control TerminatedThe primary objective of this study is to evaluate the long-term safety and tolerability of efavaleukin alfa in participants with moderate to severe ulcerative colitis (UC).
Phase: PHASE2 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New brain stimulation method could ease Parkinson's symptoms
Symptom relief Recruiting nowMany patients have benefited from the implantation of brain stimulation electrodes for the treatment of various motor signs of Parkinson's disease in the phase of motor fluctuations. This technique has significantly improved the motor symptomatology of Parkinson's disease and the…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Could a simple iron shot boost energy in heart failure?
Symptom relief Recruiting nowObservational cohort randomized controlled study to study the influence of correction of ID by intravenous injection of ferric carboxymaltose (Ferinject®) on quality of life indicators, functional status in a cohort of patients with HFpEF.
Phase: PHASE4 • Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Fall-proof training for Alzheimer's patients shows promise
Symptom relief Recruiting nowThis study will examine the overall capacity of people with Alzheimer's disease learning fall-resistant skills from perturbation training.
Phase: NA • Sponsor: Georgia State University • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Could a tiny dose of naltrexone ease HIV nerve pain without opioids?
Symptom relief Recruiting nowThe increased life expectancy of Patients Living With HIV/AIDS (PLWHA) has increased the need for therapies for chronic conditions, such as chronic pain. Pain in the HIV population is often refractory and ends up being treated with chronic opioids, which are associated with adver…
Phase: PHASE4 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Can walking during chemo reduce side effects? new study aims to find the best dose
Symptom relief Recruiting nowThe purpose of this study is to find the level of aerobic exercise (AT) that is practical, is safe, and has positive effects on the body that may reduce the side effects of therapy. The study will also look at the way the body responds to exercise and whether there are difference…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Can a daily powder boost iron levels in women? new study investigates
Disease control CompletedThe goal of this clinical trial is to determine if taking a mineral-enriched powder can raise blood iron levels compared to a placebo powder in reproductive-aged women with iron deficiency. The main questions it aims to answer are: * Does the mineral-enriched powder raise blood …
Phase: PHASE2 • Sponsor: Carleton University • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC